Excavating the surface-associated and secretory proteome of Mycobacterium leprae for identifying vaccines and

Aarti Rana1, Shweta Thakur1, Nupur Bhardwaj1

  • 1School of Life Sciences, Central University of Himachal Pradesh, Shahpur, District-Kangra, Himachal Pradesh-176206, India.

Pathogens and Disease
|November 19, 2016
PubMed

Insights

This study identifies novel surface-associated and secretory proteins (SASPs) in Mycobacterium leprae, including essential outer membrane proteins (OMPs). These OMPs contain potential epitopes for developing new immunotherapeutics against leprosy.

Area of Science:

  • Microbiology and Immunology
  • Computational Biology
  • Protein Bioinformatics

Background:

  • Leprosy, caused by Mycobacterium leprae, remains a global health challenge despite existing treatments.
  • Surface-associated and secretory proteins (SASPs) are crucial for bacterial survival and are promising targets for therapeutic intervention.

Purpose of the Study:

  • To perform a proteome-wide identification of SASPs in Mycobacterium leprae.
  • To computationally identify immunodominant epitopes within SASPs, particularly outer membrane proteins (OMPs), for potential immunotherapeutic development.

Main Methods:

  • Integrated biological knowledge with computational approaches for proteome-wide SASP identification.
  • Utilized known protein sequence and structural characteristics of bacterial SASPs.
  • Performed immunoinformatics analysis to assign T-cell and B-cell epitopes on identified OMPs.

Main Results:

  • Identified 17 lipoproteins, 11 secretory proteins, and 19 novel outer membrane proteins (OMPs) in M. leprae, including 4 essential proteins.
  • Found that 19 OMPs contain T-cell MHC class I and class II epitopes against various human HLA alleles (DR, DQ, DP).
  • Detected B-cell epitopes on 11 M. leprae OMPs, indicating their potential as antigenic candidates.

Conclusions:

  • The identified SASPs, especially OMPs, represent valuable targets for novel anti-leprosy strategies.
  • The characterized epitopes on M. leprae OMPs provide a foundation for developing new immunotherapeutics against leprosy.